Aptose Biosciences Statistics
Share Statistics
Aptose Biosciences has 60.18M shares outstanding. The number of shares has increased by 278.69% in one year.
| Shares Outstanding | 60.18M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 228.68% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 56.47M |
| Failed to Deliver (FTD) Shares | 40.93K |
| FTD / Avg. Volume | 0.62% |
Short Selling Information
The latest short interest is 187.75K, so 0.32% of the outstanding shares have been sold short.
| Short Interest | 187.75K |
| Short % of Shares Out | 0.32% |
| Short % of Float | 0.34% |
| Short Ratio (days to cover) | 0.15 |
Valuation Ratios
The PE ratio is -0.34 and the forward PE ratio is -0.18.
| PE Ratio | -0.34 |
| Forward PE | -0.18 |
| PS Ratio | 0 |
| Forward PS | 0.4 |
| PB Ratio | -5.91 |
| P/FCF Ratio | -0.38 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Aptose Biosciences Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.78, with a Debt / Equity ratio of 0.
| Current Ratio | 0.78 |
| Quick Ratio | 0.78 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 17.65% and return on capital (ROIC) is 2776.03%.
| Return on Equity (ROE) | 17.65% |
| Return on Assets (ROA) | -3.94% |
| Return on Capital (ROIC) | 2776.03% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -1.46M |
| Employee Count | 35 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -89.14% in the last 52 weeks. The beta is 1.36, so Aptose Biosciences 's price volatility has been higher than the market average.
| Beta | 1.36 |
| 52-Week Price Change | -89.14% |
| 50-Day Moving Average | 0.28 |
| 200-Day Moving Average | 0.67 |
| Relative Strength Index (RSI) | 50.03 |
| Average Volume (20 Days) | 6.55M |
Income Statement
| Revenue | n/a |
| Gross Profit | -474.55K |
| Operating Income | -52.36M |
| Net Income | -51.21M |
| EBITDA | -52.27M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -7.58 |
Balance Sheet
The company has 9.25M in cash and 1.01M in debt, giving a net cash position of 8.24M.
| Cash & Cash Equivalents | 9.25M |
| Total Debt | 1.01M |
| Net Cash | 8.24M |
| Retained Earnings | -515.54M |
| Total Assets | 10.93M |
| Working Capital | 477.00K |
Cash Flow
In the last 12 months, operating cash flow was -44.59M and capital expenditures -29.00K, giving a free cash flow of -44.62M.
| Operating Cash Flow | -44.59M |
| Capital Expenditures | -29.00K |
| Free Cash Flow | -44.62M |
| FCF Per Share | -6.61 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
APTO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -3158.33% |
| FCF Yield | -311.52% |
Analyst Forecast
The average price target for APTO is $5, which is 1983.3% higher than the current price. The consensus rating is "Buy".
| Price Target | $5 |
| Price Target Difference | 1983.3% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Jun 6, 2023. It was a backward split with a ratio of 1:15.
| Last Split Date | Jun 6, 2023 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -10.44 |
| Piotroski F-Score | 1 |